J&
Johnson & Johnson
🇺🇸XNYS.JNJUnited StatesHealthcare
$267.35USDup +0.37 (+0.14%)ClosedDelayed10:22 PM
Price$267.35+0.37 (+0.14%)
Profile
- Healthcare
- Drug Manufacturers - General
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US4781601046
- CUSIP
- 478160104
Company
- Employees
- 138,200
- Headquarters
- New Brunswick, United States
- Website
- https://www.jnj.com
- CEO
- Mr. Joaquin Duato
Market
- Shares outstanding
- 2.4B
- Market cap
- $644.29B
Key dates
- Next earnings
- Oct 13, 2026
Highlights
- Market cap
- $643.39B
- EPS LTM
- $8.62
- P/E LTM
- 31.01calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 1.93%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- $97.93B+8.06%up year on year
- Net income
- $21.04B-7.17%down year on year
- Gross margin
- 67.91%-0.01%down year on year
- Free cash flow
- $18.71B+14%up year on year
Other listings
- XHAM.JNJHamburg Stock Exchange
- XFRA.JNJFrankfurt Stock Exchange
- XMEX.JNJMexican Stock Exchange
- XSTU.JNJStuttgart Stock Exchange
- XETR.JNJXetra
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.